Structure-based design of immunologically active therapeutic peptides

Immunologic Research

Volumn 17, Issue 1-2, 1998, Pages 163-169

  Murali, Ramachandran ^a   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD4; CDR; Cystine knot; Immunoglobulin; Peptidomimetics; Receptors; TNF

Indexed keywords

CD40 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; ELECTRICITY; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

EID: 0031942763     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786441     Document Type: Article

References (54)

1. Winter G, Milstein C: Man made antibodies. Nature 1991;349:293-299.
2. Pack P, Plückthun A: Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in E. coli. Biochemistry 1992;31:1579-1584.
3. Saragovi HU, Greene MI: Constrained peptides and mimetics as probes of protein secondary structures. Immunomethods 1992;1:5-9.
4. Saragovi HU, Greene MI, Chrusciel RA, Kahn M: Loops and secondary structure mimetics: development and applications in basic science and rational drug design. Bio/Technology 1992;10:773-778.
5. Zhang X, Piatier-Tonneau P, Auffray C, Murali R, Mahapatra A, Zhang F, et al.: Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation. Nature Biotechnology 1996;14:472-475
6. Zhang X, Gaubin M, Briant L, Srikantan V, Murali R, Saragovi MH, et al.: Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes. Nature Biotechnol 1997;15:150-154.
7. Wataru T, Yuri K, Kiichi K, Murali, R, Greene MI: Structure based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor Nataure Biotechnol 1997; 15:1266-1270.
8. Janin J, Wodak SJ: Structural domains in proteins and their role in the dynamics of proein function. Prog Biophys Mol Biol 1983;42:21-78.
9. Leszczynski JF, Rose GD: Loops in globular proteins: a novel category of secondary structure. Science 1986;234:849-855.
10. Ring CS, Kneller DG, Langridge R, Cohn FE: Taxonomy and conformational analysis of loops in proteins. J Mol Biol 1992;224:685-699.
11. Bruccoleri RE, Haber E, Novotny J: Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature 1988;335:564-568.
12. Madal C, Kingery DB, Anchin JM, Subramaniam S, Linthicum, SD: ABGEN: A knowledge-based automated approach for antibody structure modeling. Nature Biotechnol 1996;14:323-328.
13. Williams AF: A year in the life of the immunoglobulin superfamily. Immunol Today 1987;8:298-303.
14. Williams WV, Guy HR, Rubin DH, Robey F, Myers JN, Emmons TK, et al.: Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures. Proc Natl Acad Sci USA 1988;85:6488-6492.
15. Saragovi HU, Fitzpatrick D, Raktabutr A, Nakanishi H, Kahn M, Greene, MI: Design and synthesis of a mimetic from an antibody complementarity-determining region. Science 1991;253:792-795.
16. Gaulton GN, Greene MI: Inhibition of cellular DNA synthesis by reovirus occurs by a reovirus receptor linked signaling pathway which is is mimicked by anti-receptor antibody. J Exp Med 1989;169:197-212.
17. Chen S, Chrusciel RA, Nakanishi H, Raktabutr A, Johnson ME, Saragovi HU, Greene MI, Kahn M: CD4 peptidomimetics that inhibit gp120 binding. Proc Natl Acad Sci USA 1992;89:5872-5876.
18. Sibanda, BL, Blundell T, Thorton J: Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J Mol Biol 1989;206:759-777.
19. McDonald NQ, Hendrickson WA: A structural superfamily of growth factors containing a cystine knot motif. Cell 1993;73:421-424.
20. Isaacs, NW: Cystine knots Curr Opin Struct Biol 1995;5:391-395.
21. Murray-Rust J, McDonald NQ, Blundell TL, Hosang M, Oefner C, Winkler F, Bradshaw RA: Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure 1993;1:153-159.
22. Ward CW, Hoyne PA, Flegg RH: Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the rumor necrosis factor receptor. Proteins 1995;22:141-153.
23. Eck MJ, Sprang SR. The structure of tumor necrosis factor-a at 2.6 Å resolution. J Biol Chem 1989;264: 17,595-17,605.
24. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR. The structure of human lymphotoxin (tumor necrosis factor-b) at 1.9-Å resolution. J Biol Chem 1992;267:2119-2122.
25. Dougall WC, Peterson NC, Greene MI: Antibody-structure-based design of pharmacological agents. Trends Biotechnol 1994;12:372-379.
26. Peterson NC, Greene MI: Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size. Therapeutic Immunol 1994;1:289-295.
27. Bach AC, Eyermann CJ, Gross JD, Bower MJ, Harlow RL, Weber PC, etal.: Structural studies of a family of high affinity ligands for GPIIb/IIIa. J Am Chem Soc 1994;116:3207-3219.
28. Jackson S, Degrade W, Dwivedi A, Parthasarathy A, Higley A, Krywko J, et al.: Template-constrained cyclic peptides: design of high-affinity ligands for GPIIb/IIIa. J Am Chem Soc 1994;116:3220-3230.
29. Bhat TN, Bentley GA, Boulot G, Greene MI, Souchon H, Schwartz FP, et al: Bound water molecules help mediate antigen-antibody association. Proc Natl Acad Sci USA 1994;91,1089-1093.
30. Gay D, Maddon P, Sekaly R, Talle MA, Godfrey M, Long E, et al.: Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 1987; 328, 626-629.
31. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, et al.: Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (Lond) 1990;348:419-426.
32. Wang J, Yan Y, Garett TPJ, Liu J, Rodgers DW, Garlick RL, et al.: Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (Lond) 1990;348:411-418.
33. Wu H, Kwong PD, Hendrickson WA: Dimeric association and segmental variability in the structure of human CD4. Nature. 1997;387:527-530
34. Langedijk PMJ, Puijk WC, Hoorn WP, Meloen R: Location of CD4 dimerization site explains critical role of CDR30like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J Biol Chem 1993;268:16,875-16,878
35. Moebius U, Clayton LK, Abraham S, Harrison SC, Reinherz EL: The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med 1992;176:507-517.
36. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, et al.: Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-481.
37. Fleury S, Lamarre D, Meloche S, Ryu SE, Cantin C, Hendrickson WA, et al.: Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 1991;66:1037-1049.
38. Brodsky MH, Warton M, Myers RM, Littman D: Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 1990;144:3078-3086.
39. Clayton LK, Hussey RE, Steinbrich R, Rama-Chandran H, Husain Y, Reinherz EL: 1988. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature 1988;335:363-366.
40. Mizukami T, Fuerst TR, Berger EA, Moss B: Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci USA 1988;85:9273-9277.
41. Peterson A, Seed B: 1988. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72.
42. Lamarre D, Ashkenazi A, Fleury S, Smith DH, Sekaly RP, Capon, DJ: 1989. The MHC-binding and gp120-binding functions of CD4 are separable. Science 1989;245:743-746.
43. Ashkenazi A, Presta LG, Marster SA, Camerato TR, Rosenthal KA, Fendly BM, Capon, DJ: Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci USA 1990;87:7150-7154.
44. Tsui P, Sweet RW, Sathe G, Rosenberg M: An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J Biol Chem 1992;267:9361-9367.
45. Houlgatte R, Scarmato P, El Marhomy S. Martin M, Ostankovitch M, Lafosse S, et al.: HLA class II antigens and the human immunodeficiency virus envelope glycoprotein gp120 bind to the same face of CD4. J Immunol 1994;152:4475-4488.
46. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.
47. Beutler B: TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 1995; 43:227-235 .
48. Döring E, Stigler R, Grütz G, Baehr R, Schneider-Mergener J: Identification and characterization of a TNFa antagonist derived from a monoclonal antibody. Mol Immunol 1994;31:1059-1067.
49. Hwang C, Gatanga M, Innins EK, Yamamoto RS, Granger GA, Gatanga T: A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumor necrosis factor in vitro. Proc R Soc Lond 1991;B245:115-119.
50. Lie B-L, Tunemoto D, Hemmi H, Mizukami Y, Fukuda H, Kikuchi H, et al.: Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides. Biochem Biophys Res Commun 1992;188:503-509.
51. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld H-J, Broger C, et al.: Crystal structure of the soluble human 55 kd TNF receptor-human TNFb complex: implications for TNF receptor activation. Cell 1993;73:431-445.
52. Naismith JH, Devine TQ, Brandhuber BJ, Sprang SR: Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem 1995;270:13,303-13,307.
53. Bazan FJ: Emerging families of cytokines and receptors. Curr Biol 1993;3:603-606.
54. Gruss HJ, Dower S: The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol Ther 1995;1:75-105.